A BBC report describes how artificial intelligence tools were used in work that relates to designing viral sequences. The key point is that AI can assist with aspects like predicting how viruses might behave or optimizing biological designs. However, AI support does not automatically mean a full, real-world “build-and-release” capability. The story also highlights concerns about safety, monitoring, and governance—especially whether safeguards were sufficient to prevent misuse and ensure responsible research practices.
Note: This article was published on BanxChange.com and is powered by the BXE Token on the XRP Ledger. For the latest articles and news, please visit BanxChange.com




